Dr. Neutrology Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 02-11-2024
- Paid Up Capital ₹ 0.10 M
as on 02-11-2024
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 2.70 M
as on 02-11-2024
- Revenue 140.16%
(FY 2023)
- Profit 114.47%
(FY 2023)
- Ebitda 350.99%
(FY 2023)
- Net Worth 38.87%
(FY 2023)
- Total Assets 21.21%
(FY 2023)
About Dr. Neutrology
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹2.70 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sanjiv Mishra, Karanvir Singh, and Dharam Singh serve as directors at the Company.
- CIN/LLPIN
U24246PB2020PTC051161
- Company No.
051161
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jun 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Rupnagar, Punjab, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Dr. Neutrology Private Limited offer?
Dr. Neutrology Private Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, Pharmaceutical Third Party Manufacturing.
Who are the key members and board of directors at Dr. Neutrology?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjiv Mishra  | Director | 08-Jul-2024 | Current |
| Karanvir Singh | Director | 11-Jun-2020 | Current |
| Dharam Singh | Director | 11-Jun-2020 | Current |
Financial Performance of Dr. Neutrology.
Dr. Neutrology Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 140.16% increase. The company also saw a substantial improvement in profitability, with a 114.47% increase in profit. The company's net worth Soared by an impressive increase of 38.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr. Neutrology?
Unlock access to Dr. Neutrology's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 20 Dec 2020 | ₹0.50 M | Satisfied |
Others Creation Date: 03 Dec 2020 | ₹2.20 M | Satisfied |
How Many Employees Work at Dr. Neutrology?
Dr. Neutrology has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr. Neutrology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. Neutrology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
